compared the efficacy and safety of a basal-bolus insulin regimen with that of sliding-scale regular insulin (SSI) in hospitalized general medical patients with type 2 diabetes. The prospective ...

Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in the U.S.

In addition to holding a reservoir of insulin, they automatically insert a small cannula (thin tube) through the skin after being attached, communicate wirelessly with a control system, and pump ...

A check mark. It indicates that the relevant content has been reviewed and verified by an expert Our stories are reviewed by medical professionals to ensure you get the most accurate and useful ...

Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for type 2 diabetes.

Insulin pumps are a medical device used by people ... Traditionally they have involved a canula and separate connected pump, but more recent models have taken the form of a patch with a pump ...

The technology known as Advance-Hybrid Closed-Loop consists of an algorithm on an insulin pump which communicates ... When the Temp Target is on, auto-bolus corrections are disabled.

Enhanced extended bolus up to 8 hours with Control-IQ+ turned ... for use with NovoLog or Humalog U-100 insulin. t:slim X2 insulin pump: The pump is intended for the subcutaneous delivery of ...

parameters to accommodate a wider range of insulin requirements. Enhanced extended bolus up to 8 hours with Control-IQ+ turned on, for better management for meals with delayed glucose rise or ...

Enhanced extended bolus up to 8 hours with Control-IQ+ turned ... features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ+ advanced hybrid closed-loop ...